Page 51 - GPD-3-3

Gene & Protein in Disease Phage therapy for Mycobacterium infections

doi: 10.1146/annurev-virology-122019-070009 48. Wei L, Wu J, Liu H, et al. A mycobacteriophage-derived
trehalose-6,6’-dimycolate-binding peptide containing both
36. Hatfull GF. Complete genome sequences of 138 antimycobacterial and anti-inflammatory abilities. FASEB J.
mycobacteriophages. J Virol. 2012;86(4):2382-2384.
2013;27(8):3067-3077.
doi: 10.1128/jvi.06870-11
doi: 10.1096/fj.13-227454
37. Henry M, O’Sullivan O, Sleator RD, et al. In silico analysis
of Ardmore, a novel mycobacteriophage isolated from soil. 49. Arranz-Trullén J, Lu L, Pulido D, Bhakta S, Boix E. Host
Gene. 2010;453(1-2):9-23. antimicrobial peptides: The promise of new treatment
strategies against tuberculosis. Front Immunol. 2017;8:1499.
doi: 10.1016/j.gene.2009.12.007
doi: 10.3389/fimmu.2017.01499
38. Pope WH, Ferreira CM, Jacobs-Sera D, et al. Cluster K 50. Wang J, Yuan T, He X, et al. Production, characterization,
mycobacteriophages: Insights into the evolutionary origins and application of phage-derived PK34 recombinant
of mycobacteriophage TM4. PLoS One. 2011;6(10):e26750.
anti-microbial peptide. Appl Microbiol Biotechnol.
doi: 10.1371/journal.pone.0026750 2023;107(1):163-174.
39. Pope WH, Jacobs-Sera D, Russell DA, et al. Expanding doi: 10.1007/s00253-022-12306-1
the diversity of mycobacteriophages: Insights into genome 51. Chen JM, Ren H, Shaw JE, et al. Lsr2 of Mycobacterium
architecture and evolution. PLoS One. 2011;6(1):e16329.
tuberculosis is a DNA-bridging protein. Nucleic Acids Res.
doi: 10.1371/journal.pone.0016329 2008;36(7):2123-2135.
40. Hatfull GF, Hendrix RW. Bacteriophages and their genomes. doi: 10.1093/nar/gkm1162
Curr Opin Virol. 2011;1(4):298-303.
52. Gordon BR, Li Y, Cote A, et al. Structural basis for recognition
doi: 10.1016/j.coviro.2011.06.009 of AT-rich DNA by unrelated xenogeneic silencing proteins.
41. Crane A, Versoza CJ, Hua T, et al. Phylogenetic relationships Proc Natl Acad Sci U S A. 2011;108(26):10690-10695.
and codon usage bias amongst cluster K mycobacteriophages. doi: 10.1073/pnas.1102544108
G3 (Bethesda). 2021;11(11):jkab291.
53. Gordon BR, Li Y, Wang L, et al. Lsr2 is a nucleoid-associated
doi: 10.1093/g3journal/jkab291 protein that targets AT-rich sequences and virulence genes
in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A.
42. Hatfull GF. Mycobacteriophages: Genes and genomes. Annu
Rev Microbiol. 2010;64:331-356. 2010;107(11):5154-5159.
doi: 10.1073/pnas.0913551107
doi: 10.1146/annurev.micro.112408.134233
54. Summers EL, Meindl K, Usón I, et al. The structure of
43. Froman S, Will DW, Bogen E. Bacteriophage active against the oligomerization domain of Lsr2 from Mycobacterium
virulent Mycobacterium tuberculosis. I. Isolation and activity.
Am J Public Health Nations Health. 1954;44(10):1326-1333. tuberculosis reveals a mechanism for chromosome
organization and protection. PLoS One. 2012;7(6):e38542.
doi: 10.2105/ajph.44.10.1326
doi: 10.1371/journal.pone.0038542
44. Sinha A, Eniyan K, Manohar P, Ramesh N, Bajpai U.
Characterization and genome analysis of B1 sub-cluster 55. Gordon BR, Imperial R, Wang L, Navarre WW, Liu J. Lsr2
of Mycobacterium represents a novel class of H-NS-like
mycobacteriophage PDRPxv. Virus Res. 2020;279:197884.
proteins. J Bacteriol. 2008;190(21):7052-7059.
doi: 10.1016/j.virusres.2020.197884
doi: 10.1128/jb.00733-08
45. Hatfull GF. The secret lives of mycobacteriophages. Adv
Virus Res. 2012;82:179-288. 56. Báez-Ramírez E, Querales L, Aranaga CA, et al. Elimination
of PknL and MSMEG_4242 in Mycobacterium smegmatis
doi: 10.1016/b978-0-12-394621-8.00015-7 alters the character of the outer cell envelope and selects for
mutations in Lsr2. Cell Surf. 2021;7:100060.
46. Jeżowska-Bojczuk M, Stokowa-Sołtys K. Peptides having
antimicrobial activity and their complexes with transition doi: 10.1016/j.tcsw.2021.100060
metal ions. Eur J Med Chem. 2018;143:997-1009.
57. Bartek IL, Woolhiser LK, Baughn AD, et al. Mycobacterium
doi: 10.1016/j.ejmech.2017.11.086 tuberculosis Lsr2 is a global transcriptional regulator
required for adaptation to changing oxygen levels and
47. Su Z, Huang Y, Zhou Q, et al. High-level expression
and purification of human epidermal growth factor virulence. mBio. 2014;5(3).
with SUMO fusion in Escherichia coli. Protein Pept Lett. doi: 10.1128/mBio.01106-14
2006;13(8):785-792.
58. Kocíncová D, Singh AK, Beretti JL, et al. Spontaneous
doi: 10.2174/092986606777841280 transposition of IS1096 or ISMsm3 leads to

Volume 3 Issue 3 (2024) 12 doi: 10.36922/gpd.2935